%0 Journal Article
%T IMPORT-201 (IMP-MEL): A phase 1 first-in-human dose finding/randomized phase 2 study of a novel iNKT agonist IMM60 and pembrolizumab for advanced melanoma and metastatic non-small cell lung cancer (NSCLC).
%A Coupe, Nicholas
%A Pinato, David J. James
%A Fairchild, Justin P.
%A Pastore, Desa Rae Electa
%A Innaimo, Steven
%A Thompson, David
%A Gileadi, Uzi
%A Kramer, Robert A.
%A Walters, Ian B.
%A Middleton, Mark R.
%J Journal of Clinical Oncology
%V 41
%N 16_suppl
%P 2575-2575
%@ 0732-183X
%D 2023-06-01
%I American Society of Clinical Oncology
%~ DeepDyve